Urolithiasis: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Robert Badgett |
||
| Line 15: | Line 15: | ||
* [[Uric acid]] | * [[Uric acid]] | ||
* Struvite | * Struvite | ||
* [[ | * [[cystine ]] | ||
==Treatment== | ==Treatment== | ||
Revision as of 10:16, 9 January 2014
In medicine, urolithiasis if the "formation of stones in any part of the urinary tract, usually in the kidney; urinary bladder; or the ureter."[1]
Classification
Etiology/cause
- Hypercalcuria - >140 mg/gm of urine creatinine or >4 mg/kg of body weight
- Hyperoxaluria - >40mg in 24 hour urine. May be primary or secondary to disorders such as inflammatory bowel disease
- Hypocitruria
- Uric acid
- Struvite
- cystine
Treatment
Prevention
Chlorthalidone reduces recurrence of calcium oxalate stones.[2][3]
References
- ↑ Anonymous (2024), Urolithiasis (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Ettinger B, Citron JT, Livermore B, Dolman LI (1988). "Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not.". J Urol 139 (4): 679-84. PMID 3280829.
- ↑ Escribano J, Balaguer A, Pagone F, Feliu A, Roqué I Figuls M (2009). "Pharmacological interventions for preventing complications in idiopathic hypercalciuria.". Cochrane Database Syst Rev (1): CD004754. DOI:10.1002/14651858.CD004754.pub2. PMID 19160242. Research Blogging.